We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 10, 2020

BCI Predicts Extended Endocrine Benefit to Individualize Patient Selection

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients With HR+ Early-Stage Breast Cancer for 10 Years of Endocrine Therapy
Clin. Cancer Res 2020 Oct 27;[EPub Ahead of Print], I Noordhoek, K Treuner, H Putter, Y Zhang, J Wong, E Meershoek-Klein Kranenbarg, M Duijm-de Carpentier, CJH van de Velde, CA Schnabel, GJ Liefers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading